Assessment and Management of Cancer- and Cancer Treatment–Related Cognitive Impairment

Deborah H. Allen, Jamie S. Myers, Catherine E. Jansen, John Merriman, Diane Von Ah

Research output: Contribution to journalLiterature review

Abstract

Cognitive impairment resulting from cancer and subsequent treatment is one of the most common and troubling sequelae experienced by cancer survivors. Cancer survivors report that cognitive impairment negatively affects their quality of life. Appropriate assessment and management of cognitive impairment is critical to providing optimal care to cancer survivors. The purpose of this article is to briefly describe the state of evidence on incidence, possible mechanisms, and presentation of cancer- and cancer treatment–related cognitive impairment and to provide guidance for its assessment and management. We focus on management with nonpharmacological and pharmacological interventions that may have clinical utility.

Original languageEnglish (US)
Pages (from-to)217-224.e5
JournalJournal for Nurse Practitioners
Volume14
Issue number4
DOIs
StatePublished - Mar 5 2018

Fingerprint

Survivors
Neoplasms
Cognitive Dysfunction
Quality of Life
Pharmacology
Incidence
Therapeutics

Keywords

  • cancer survivorship
  • cancer- and cancer treatment–related cognitive impairment
  • cognitive training
  • exercise and physical activity
  • psychostimulants

ASJC Scopus subject areas

  • Fundamentals and skills
  • LPN and LVN

Cite this

Assessment and Management of Cancer- and Cancer Treatment–Related Cognitive Impairment. / Allen, Deborah H.; Myers, Jamie S.; Jansen, Catherine E.; Merriman, John; Von Ah, Diane.

In: Journal for Nurse Practitioners, Vol. 14, No. 4, 05.03.2018, p. 217-224.e5.

Research output: Contribution to journalLiterature review

Allen, Deborah H. ; Myers, Jamie S. ; Jansen, Catherine E. ; Merriman, John ; Von Ah, Diane. / Assessment and Management of Cancer- and Cancer Treatment–Related Cognitive Impairment. In: Journal for Nurse Practitioners. 2018 ; Vol. 14, No. 4. pp. 217-224.e5.
@article{233709164b18403490c8b975fb605b02,
title = "Assessment and Management of Cancer- and Cancer Treatment–Related Cognitive Impairment",
abstract = "Cognitive impairment resulting from cancer and subsequent treatment is one of the most common and troubling sequelae experienced by cancer survivors. Cancer survivors report that cognitive impairment negatively affects their quality of life. Appropriate assessment and management of cognitive impairment is critical to providing optimal care to cancer survivors. The purpose of this article is to briefly describe the state of evidence on incidence, possible mechanisms, and presentation of cancer- and cancer treatment–related cognitive impairment and to provide guidance for its assessment and management. We focus on management with nonpharmacological and pharmacological interventions that may have clinical utility.",
keywords = "cancer survivorship, cancer- and cancer treatment–related cognitive impairment, cognitive training, exercise and physical activity, psychostimulants",
author = "Allen, {Deborah H.} and Myers, {Jamie S.} and Jansen, {Catherine E.} and John Merriman and {Von Ah}, Diane",
year = "2018",
month = "3",
day = "5",
doi = "10.1016/j.nurpra.2017.11.026",
language = "English (US)",
volume = "14",
pages = "217--224.e5",
journal = "Journal for Nurse Practitioners",
issn = "1555-4155",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Assessment and Management of Cancer- and Cancer Treatment–Related Cognitive Impairment

AU - Allen, Deborah H.

AU - Myers, Jamie S.

AU - Jansen, Catherine E.

AU - Merriman, John

AU - Von Ah, Diane

PY - 2018/3/5

Y1 - 2018/3/5

N2 - Cognitive impairment resulting from cancer and subsequent treatment is one of the most common and troubling sequelae experienced by cancer survivors. Cancer survivors report that cognitive impairment negatively affects their quality of life. Appropriate assessment and management of cognitive impairment is critical to providing optimal care to cancer survivors. The purpose of this article is to briefly describe the state of evidence on incidence, possible mechanisms, and presentation of cancer- and cancer treatment–related cognitive impairment and to provide guidance for its assessment and management. We focus on management with nonpharmacological and pharmacological interventions that may have clinical utility.

AB - Cognitive impairment resulting from cancer and subsequent treatment is one of the most common and troubling sequelae experienced by cancer survivors. Cancer survivors report that cognitive impairment negatively affects their quality of life. Appropriate assessment and management of cognitive impairment is critical to providing optimal care to cancer survivors. The purpose of this article is to briefly describe the state of evidence on incidence, possible mechanisms, and presentation of cancer- and cancer treatment–related cognitive impairment and to provide guidance for its assessment and management. We focus on management with nonpharmacological and pharmacological interventions that may have clinical utility.

KW - cancer survivorship

KW - cancer- and cancer treatment–related cognitive impairment

KW - cognitive training

KW - exercise and physical activity

KW - psychostimulants

UR - http://www.scopus.com/inward/record.url?scp=85042860986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042860986&partnerID=8YFLogxK

U2 - 10.1016/j.nurpra.2017.11.026

DO - 10.1016/j.nurpra.2017.11.026

M3 - Literature review

VL - 14

SP - 217-224.e5

JO - Journal for Nurse Practitioners

JF - Journal for Nurse Practitioners

SN - 1555-4155

IS - 4

ER -